Valnoctamide-d5 C-pPhCO2Me InChi: InChI=1S/C20H31NO11/c1-25-6-7-26-8-9-27-10-11-28-12-13-29-14-15-30-16-17-31-20(22)32-19-4-2-18(3-5-19)21(23)24/h2-5H

InChi: InChI=1S/C20H31NO11/c1-25-6-7-26-8-9-27-10-11-28-12-13-29-14-15-30-16-17-31-20(22)32-19-4-2-18(3-5-19)21(23)24/h2-5H

twice daily orally for 14 days) dose-dependently reduced tumor growth and also dose-dependently reduced weight of the palpable tumors at termination

25-Dihydroxycholecalciferol) is an inactive form of vitamin D3 which undergoes various levels of hydroxylation to form active vitamin D3 analogs

6R)-6-[(2R)-2-[(2R)-2-amino-3-(methylcarbamoyl)propanamido]-2-(4-hydroxyphenyl)acetamido]-3

Valnoctamide-d5 C-pPhCO2Me InChi: InChI=1S/C20H31NO11/c1-25-6-7-26-8-9-27-10-11-28-12-13-29-14-15-30-16-17-31-20(22)32-19-4-2-18(3-5-19)21(23)24/h2-5HValnoctamide d5 (Valmethamide d5) is the deuterium labeled Valnoctamide. Valnoctamide (Valmethamide), a derivative of valproate, suppresses benzodiazepine refractory status epilepticus. Valnoctamide (Valmethamide) acts directly on GABAA receptors. Product information CAS Number: 1190015 82 7 Molecular Weight: 148. 26 Formula: C8H17NO Chemical Name: 2 [(1,1,2,2,2 H)ethyl] 3 methylpentanamide Smiles: [2H]C([2H])([2H])C([2H])([2H])C(C(C)CC)C(N)=O